Key Takeaways
Treat government as a market-maker, not merely a market repair crew.
More than a safety net. The Entrepreneurial State is a government that actively invests in uncertain technologies, creates new markets, and helps innovations reach commercial use. This differs from the standard market-failure view, where government steps in only when private firms underinvest in public goods such as basic research. Mazzucato argues that public agencies have also pursued opportunities businesses had not yet imagined, including the Internet and nanotechnology.
Vision changes the role. The book points to mission-led investment, procurement, and coordination across agencies as ways public institutions can make new industries possible. The goal is not to replace private enterprise, but to take on early risks and establish opportunities that private firms can build on. The state is not simply reducing business risk; it can lead where private investors hesitate.
The market-maker idea usefully shifts attention from whether government intervenes to what its intervention is designed to accomplish. Public procurement, for example, can create an initial customer for a technology before a mass market exists. That is a different economic function from correcting an externality. The distinction also raises a practical question: who defines the mission, and how can citizens contest it? Public ambition needs independent scrutiny, transparent objectives, and room to revise failed approaches. The case for a capable state is strongest when paired with limits on capture and a clear account of public benefit.
Judge innovation by connected capabilities, not R&D totals or patent counts.
Innovation is a system. A system of innovation is the network of firms, researchers, public agencies, financiers, and institutions that produces and spreads useful knowledge. Research spending matters, but its effects depend on how knowledge connects to production, skilled workers, suppliers, customers, and investment. Patent totals can also mislead: legal changes and defensive patenting can increase filings without producing more valuable products.
Japan outconnected the USSR. In the 1970s, Japan spent about 2.5 percent of GDP on R&D, while the Soviet Union spent more than 4 percent. Yet Japan linked company research to manufacturing and international markets; more than two-thirds of its R&D took place at the enterprise level. The Soviet Union concentrated over 70 percent of R&D in military and space work, with weak links to civilian production. How knowledge moved mattered as much as how much was spent.
This account anticipates a key lesson of network science: the value of a node depends partly on its connections. A laboratory discovery creates little economic change if firms cannot test, manufacture, finance, and distribute applications. The Japan-USSR comparison makes that institutional point vivid, though national averages can conceal differences among industries and firms. R&D and patents remain useful signals, not useless ones; the error is treating either as a complete measure of innovative capacity. Evaluation should track diffusion, productive use, and the institutions that help knowledge travel.
Venture capital usually follows uncertainty after the first leap.
Risk arrives in stages. Venture capital is private investment in young firms expected to grow quickly, often with the aim of selling a stake through an acquisition or public offering. The book argues that this model is poorly suited to the earliest, most uncertain, capital-intensive work. In one cited estimate, the risk of loss was 66.2 percent at the seed stage and 20.1 percent by the third stage. Public research and early public financing often make later private investment more attractive.
Time horizons matter. Venture funds may last ten years, but investors often seek an exit within three to five years to show returns and raise another fund. That timetable can clash with technologies that need longer development and expensive manufacturing. In biotechnology, venture capital arrived after public science had built much of the underlying knowledge. Its role can be valuable, but it is not proof that private finance takes the first or greatest risk.
The distinction between risk and uncertainty sharpens the argument. Risk can be estimated from known outcomes; genuine uncertainty concerns situations without a reliable probability distribution, such as whether a new technical field will become commercially useful. Investors with finite fund lives have structural reasons to prefer nearer-term opportunities. Still, venture capital is not a single uniform actor: some investors supply expertise, networks, and patient commitments, while others emphasize quick exits. Good policy should match financing to technology timelines rather than assume one financial instrument can carry every stage.
The iPhone's genius was integration; its foundations were publicly built.
A product can hide its origins. Mazzucato traces technologies in Apple's products to decades of public research and procurement. The Internet, GPS, touch-screen systems, microelectronics, and the research behind SIRI each had substantial public roots. The government also supported Apple directly: before its 1980 public offering, the company received a $500,000 early investment through a federally licensed Small Business Investment Company.
Apple added the architecture. Public investment did not design the iPhone or make its user experience effortless. Apple's contribution was to select, combine, refine, and market technologies in a coherent product. In the five years after the iPhone launched in 2007, Apple's global sales rose nearly 460 percent. The book's point is not that government deserves all the credit, but that the familiar tale of a lone company inventing from scratch leaves out the public platform that made its leap possible.
The Apple case is persuasive because it separates invention from integration, two activities often collapsed into a single story of innovation. A technology can emerge from public research, then acquire value through private design, organizational skill, and distribution. This is closer to an ecology than a contest over which sector deserves sole credit. The case also has a boundary: tracing public origins does not by itself establish the right public share of every later profit. It does, however, make it harder to assess corporate success without asking who financed the enabling conditions.
Build mission agencies that connect research, firms, procurement, and commercialization.
Organize for a mission. DARPA, the US defense research agency, illustrates a public institution designed to pursue ambitious technological goals. Its program managers fund universities, start-ups, and established firms, connect researchers to potential partners, and can shift money away from projects that are not progressing. Its role goes beyond grants: it brokers networks and helps move promising work toward usable products.
Other tools fill different gaps. The Small Business Innovation Research program directs a portion of agency research budgets to small firms. The Orphan Drug Act created incentives for treatments for rare diseases, helping biotech companies build a market. In pharmaceuticals, the book reports that publicly funded laboratories contributed research behind about three-quarters of new molecular entities. These cases show that effective policy can combine research funding, procurement, finance, and market rules instead of relying on a single subsidy.
The institutional lesson is more useful than simply calling for a bigger state. DARPA's autonomy, specialized staff, networking, and ability to stop or redirect projects are design choices, not automatic features of public agencies. Those features resemble adaptive organizations that learn through experimentation rather than rigidly execute a fixed plan. Yet success stories can hide selection effects: agencies may be celebrated for visible breakthroughs while routine failures receive less attention. Mission agencies need published aims, independent evaluation, and permission to terminate projects, so experimentation does not become an excuse for unaccountable spending.
Green industries need steady demand, patient capital, and a clear technological direction.
A market must be sustained. Wind and solar compete against energy systems built over generations, so research grants alone cannot erase incumbent infrastructure and cost advantages. The global wind and solar market grew from about $7 billion in 2000 to $164 billion in 2011, but that expansion depended on public support for research, manufacturing, and demand. Germany's long-term feed-in tariffs helped create a stable market for renewable power. China paired large industrial targets with public finance and domestic market development.
Policy uncertainty is costly. The book contrasts these approaches with US and UK stop-start policies, where changing incentives made long-term investment harder. China's stated target of 1,000 gigawatts of wind capacity by 2050 expressed a sustained direction, while American firms faced uncertainty over expiring support. Venture capital alone could not reliably finance factories and years of technology development. The transition needs public finance that can wait for costs to fall and markets to mature.
This framework captures why climate policy has to coordinate technology supply with demand. A factory will not scale on research success alone; it needs customers, grid access, and confidence that rules will persist. That is a coordination problem as much as a financing problem. The risk is that a clear direction can become an inflexible bet or protect favored firms from competition. Stable policy should therefore mean predictable goals and reviewable instruments, not permanent guarantees to particular companies. The book's account is especially strong on policy continuity, while the precise best technology mix requires ongoing evidence and revision.
Make public risk-taking earn public returns, not only private fortunes.
Risk and reward have separated. The book argues that taxpayers, workers, and firms all contribute to innovation, yet financial rewards can flow disproportionately to owners and executives. In pharmaceuticals, publicly funded research underpinned many important drugs, while patients and public health systems could face high prices. The text cites Taxol, developed through National Institutes of Health research and sold by a company for about $20,000 per annual dose, with royalties to the NIH of only 0.5 percent.
Financial extraction competes with reinvestment. The author also points to share buybacks, which raise shareholder returns without necessarily building new productive capacity. Pfizer repurchased $9 billion in stock in 2011, nearly matching its R&D spending that year. When public investment bears early uncertainty but companies can avoid taxes or return cash to shareholders, the public may have little direct means to replenish the next round of research.
The distribution question is not an afterthought to innovation. It affects political consent, access to essential goods, and the resources available for future research. The strongest version of the argument does not deny that private firms add value; it asks whether their rewards are proportionate to their contribution and whether public support comes with reciprocal obligations. Direct public returns should also be distinguished from punitive or unpredictable extraction. Carefully designed royalties, pricing conditions, or equity stakes can share upside while preserving incentives, but each instrument needs transparent rules and sector-specific design.
Measure government by missions, spillovers, and shared gains, not isolated wins.
Reward can be recycled. Mazzucato proposes ways for successful public investments to help finance future innovation: royalties on publicly funded inventions, a government share in relevant intellectual property, income-contingent repayment, equity stakes, and public development banks. The Brazilian development bank BNDES, for example, reported a 21.2 percent return on equity in 2010, which could support further public investment. These mechanisms are intended to let successful bets help cover unavoidable failures.
Judge the portfolio, not just the headline. A public program may generate spillovers, skilled workers, supplier networks, or technologies used beyond its original mission. A single failed project does not settle whether the wider program was worthwhile, just as a celebrated success does not prove that every subsidy worked. Government needs transparent investment records and measures of public value, including whether private partners add their own long-term commitment and whether gains reach workers and citizens.
The proposal connects innovation policy to portfolio management: uncertain projects should be assessed as a group, with some returns sustaining future experiments. It also addresses a political problem, since visible public benefits can build support for long-term investment. The difficult part is attribution. Spillovers are diffuse, and a government stake can be costly to administer or distort company decisions if poorly designed. A credible system would combine direct financial returns where public support is identifiable with broader measures of social value, while making terms public before firms accept assistance.
Analysis
The book's central intervention is not simply that governments spend on research. It argues that public institutions have repeatedly acted as entrepreneurs: setting missions, accepting uncertainty, assembling networks, and creating markets that private firms later enter. The examples make this argument concrete. DARPA's links between laboratories and firms, the public research behind biotechnology, the technologies incorporated into the iPhone, and long-term support for wind and solar show different ways public action can shape innovation rather than merely repair a market after it fails.
Its most important analytical move is to separate innovation's collective production from the private capture of its rewards. This reframes debates over taxes, drug prices, shareholder returns, and public subsidies as questions about the terms of partnership, not just the size of government. It also explains why calls to promote small firms, patents, venture capital, or R&D spending can miss the real bottleneck: capabilities, patient finance, and links between research and production.
The evidence is strongest where the book reconstructs a specific chain of public support and private commercialization. The Apple account, for instance, shows how state-funded technologies and private systems integration can both be indispensable. The broader claims deserve careful qualification. Public investment can fail, political missions can be captured, and the existence of public research behind a successful product does not alone establish what share of profits should return to taxpayers. Historical examples demonstrate capacity, not universal competence.
The most useful reading is therefore neither a plea for unlimited state direction nor a defense of passive markets. It is an institutional challenge: build agencies with expertise, missions, feedback, and accountability; match finance to the timescale and uncertainty of each technology; and design public-private arrangements so that successful gains reinforce future public investment. The book's lasting question is practical: when society collectively makes the risky foundations of an industry, what rules ensure society shares in what follows?
Review Summary
The Entrepreneurial State challenges the notion that innovation is driven solely by the private sector. Mazzucato argues that the state plays a crucial role in funding and directing technological breakthroughs, often taking on risks that private companies avoid. She uses examples like the iPhone and pharmaceutical research to demonstrate how government investment has been essential for innovation. While some readers found the book enlightening and persuasive, others criticized its selective use of evidence and perceived bias against the private sector. Overall, the book sparked debate about the role of government in fostering innovation and economic growth.
People Also Read
Glossary
Entrepreneurial State
Public market-shaping investorA state that does more than correct market failures or subsidize private activity. It sets ambitious missions, invests in uncertain technologies, coordinates networks of researchers and businesses, and can help create markets where none yet exist. The concept emphasizes public leadership in early innovation while allowing private firms to develop and commercialize products.
Knightian uncertainty
Uncertainty without calculable oddsA condition in which outcomes cannot be assigned reliable probabilities because the situation is new or unique. It differs from measurable risk, where possible outcomes and their likelihoods can be estimated. The book uses the distinction to explain why radical innovation can deter conventional investors and why public institutions may need to finance exploratory work.
systems of innovation
Networks that produce and spread knowledgeThe public and private institutions, organizations, and relationships involved in creating, adapting, and diffusing economically useful knowledge. These systems can be regional, national, or sectoral. Their performance depends not only on research spending, but also on links among firms, universities, government agencies, finance, workers, suppliers, and users.
general purpose technologies
Technologies that transform many sectorsTechnologies with broad effects across an economy. They spread into many industries, improve over time, and enable further innovations in products and processes. The book treats technologies such as computing and the Internet as examples, and argues that their development can require long-term public investment before widespread commercial uses become clear.
Developmental State
State guiding industrial developmentA government that actively coordinates economic development rather than limiting itself to setting general rules. It may target technologies or sectors, organize finance, build institutional links, and support firms as they develop productive capabilities. The book draws on East Asian examples and argues that similar developmental activity has also been present, though less publicly acknowledged, in the United States.
patient capital
Finance with a long horizonFunding willing to remain committed through long development periods, uncertain outcomes, and the time required to build production capacity or a market. It contrasts with financing that expects a quick sale or public offering. The book identifies public investment and development banks as potential sources, especially for capital-intensive technologies such as renewable energy.
Death Valley
Gap between proof and viable productionThe difficult stage after an idea or prototype has shown promise but before a technology has been fully tested, approved, manufactured at scale, or adopted by a market. Firms can fail in this gap because private finance is unavailable or impatient. The book argues that public financing can help promising technologies cross it.
risk-reward nexus
Link between contribution and returnA framework for examining who contributes money, labor, and knowledge to innovation, who bears uncertainty, and who receives financial returns when innovation succeeds. It holds that disproportionate private rewards can deepen inequality and weaken future innovation when taxpayers and workers contribute substantially but receive little benefit.
FAQ
What's The Entrepreneurial State about?
- State's Crucial Role: The book argues that the state is a key driver of innovation and economic growth, challenging the belief that the private sector is the sole engine of entrepreneurship.
- Debunking Myths: Mariana Mazzucato debunks myths about the public and private sectors, particularly the idea that the state cannot pick winners in the economy.
- Historical and Case Studies: It provides historical examples and case studies, such as the development of the Internet and biotechnology, to show how state investments have led to significant technological advancements.
Why should I read The Entrepreneurial State?
- Challenging Conventional Wisdom: The book is essential for understanding the often-overlooked contributions of the state to innovation, which is critical in today’s economic climate.
- Policy Implications: It offers insights that can inform policymakers on how to effectively support innovation and economic growth through strategic state involvement.
- Real-World Applications: Provides concrete examples of successful state interventions, making it relevant for entrepreneurs, investors, and anyone interested in economic policy.
What are the key takeaways of The Entrepreneurial State?
- State as Innovator: The state is not just a market fixer but an active innovator that takes on risks to create new markets and technologies.
- Investment in R&D: Public investment in research and development is crucial for fostering innovation, especially in high-risk areas where private investment is scarce.
- Symbiotic Relationships: Emphasizes the importance of symbiotic relationships between the public and private sectors, where both can benefit from collaborative efforts.
What are the best quotes from The Entrepreneurial State and what do they mean?
- State's Bold Investments: “The State… ‘foolishly’ developing innovations?” highlights the paradox of the state being seen as inefficient while making bold investments in high-risk innovations.
- Proactive State Involvement: “Innovation that would not have come about had we waited for the ‘market’” emphasizes that many groundbreaking innovations were only possible due to proactive state involvement.
- Courageous State Funding: “The most radical new technologies… trace their funding to a courageous, risk-taking State” underscores the state's role in funding significant technological advancements.
How does Mariana Mazzucato define "patient capital" in The Entrepreneurial State?
- Long-Term Investment: Patient capital refers to investments made with a long-term perspective, allowing time to develop and commercialize new technologies.
- Government's Unique Role: Mazzucato argues that the government is uniquely positioned to provide patient capital, as it can afford to take on risks that private investors often avoid.
- Sustaining Innovation: By providing patient capital, the state can help sustain innovation over time, ensuring that promising technologies reach maturity and can compete in the market.
What examples does Mazzucato use to illustrate the role of the state in innovation?
- Clean Technology Investments: Discusses how countries like China and Germany have made significant public investments in clean technologies, leading to their leadership in the sector.
- Pharmaceutical Industry: Highlights how the U.S. government has funded much of the basic research that leads to new drugs, yet the profits are often privatized by pharmaceutical companies.
- DARPA's Contributions: Uses the example of DARPA to show how government-funded research has led to significant technological advancements, including the Internet and GPS.
How does The Entrepreneurial State address the issue of inequality?
- Privatization of Rewards: Argues that while the state often socializes the risks of innovation, the rewards are frequently privatized, leading to increased economic inequality.
- Call for Redistribution: Advocates for a more equitable distribution of the returns from public investments, suggesting mechanisms to ensure taxpayers benefit from the innovations they fund.
- Impact on Growth: Posits that addressing inequality is not just a social issue but also an economic one, as it can hinder innovation and growth.
What is the significance of the "Valley of Death" in innovation according to The Entrepreneurial State?
- Transition Stage: The "Valley of Death" refers to the critical phase in the innovation process where technologies move from research and development to commercialization.
- Need for Support: Emphasizes that government intervention is often necessary to bridge this gap, providing resources to help technologies survive this precarious phase.
- Long-Term Commitment: Highlights the importance of long-term commitment from both the public and private sectors to ensure that innovative ideas can be developed and brought to fruition.
How does Mazzucato propose to improve the relationship between risk and reward in innovation?
- Direct Returns to the State: Suggests that the state should receive direct returns from successful innovations it has funded, allowing it to reinvest in future projects.
- Equity Stakes: Advocates for the government to retain equity stakes in companies it supports, ensuring that taxpayers benefit from the profits generated by these firms.
- Transparent Policies: Calls for greater transparency in how public funds are used and how returns are calculated, enabling better accountability and equitable sharing of innovation benefits.
What role does venture capital play in the innovation ecosystem according to The Entrepreneurial State?
- Impatient Capital: Describes venture capital as "impatient capital," which often seeks quick returns and is less willing to invest in long-term, high-risk projects.
- Focus on Established Technologies: Venture capital tends to favor established technologies that are closer to market penetration, rather than supporting radical innovations.
- Need for Complementary Support: Argues that while venture capital is important, it should be complemented by patient capital from the state to ensure high-risk innovations can be developed and commercialized.
What are the policy implications of The Entrepreneurial State for supporting innovation?
- Strategic State Involvement: The book suggests that policymakers should recognize the state's role as an active innovator and not just a facilitator.
- R&D Investment: Emphasizes the need for increased public investment in research and development, particularly in high-risk areas.
- Equitable Returns: Advocates for policies that ensure equitable returns from public investments, benefiting taxpayers and fostering a sustainable innovation ecosystem.
How does The Entrepreneurial State challenge the conventional wisdom about innovation?
- State vs. Market: Challenges the notion that innovation is solely the product of private enterprise, highlighting the importance of public investment.
- Role of Government: Emphasizes that the government often takes on the riskiest investments that the private sector avoids.
- Interconnectedness of Sectors: Offers a fresh perspective on how innovation occurs, emphasizing the interconnectedness of public and private sectors.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.